Literature DB >> 1686854

Effects of long-term treatment with naltrexone on hepatic enzyme activity.

L A Pini1, C Ferretti, T Trenti, A Ferrari, E Sternieri.   

Abstract

The influence of naltrexone on liver function in heroin addicts was studied, with respect to the metabolizing function by using the antipyrine clearance and to cellular damage by monitoring plasma levels of hepatic enzymes. The clearance of antipyrine was not affected by naltrexone treatment, and, during the study period, the use and withdrawal of benzodiazepines and alcohol did not change this parameter; moreover, there was no relationship between changes in plasma hepatic enzymes and antipyrine half-life. Mean plasma levels of hepatic enzymes did not show significant modification in the course of treatment with naltrexone.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1686854     DOI: 10.1515/dmdi.1991.9.2.161

Source DB:  PubMed          Journal:  Drug Metabol Drug Interact        ISSN: 0792-5077


  3 in total

Review 1.  Clinical safety of 1500 mg oral naltrexone overdose.

Authors:  Albert Stuart Reece
Journal:  BMJ Case Rep       Date:  2010-09-07

2.  Hepatic safety and antiretroviral effectiveness in HIV-infected patients receiving naltrexone.

Authors:  Jeanette M Tetrault; Janet P Tate; Kathleen A McGinnis; Joseph L Goulet; Lynn E Sullivan; Kendall Bryant; Amy C Justice; David A Fiellin
Journal:  Alcohol Clin Exp Res       Date:  2011-07-28       Impact factor: 3.455

Review 3.  The use of low-dose naltrexone (LDN) as a novel anti-inflammatory treatment for chronic pain.

Authors:  Jarred Younger; Luke Parkitny; David McLain
Journal:  Clin Rheumatol       Date:  2014-02-15       Impact factor: 2.980

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.